Nearly 95% of assessed TikTok “glass skin” videos contained potentially misleading claims, with none citing external references and none produced by dermatologists.

ILT7 is selectively expressed on plasmacytoid dendritic cells, and daxdilimab binding is intended to reduce pDCs in tissue ...

Dr. Singh describes hedgehog pathway inhibitors as a frequent first-line option for patients with locally advanced basal cell carcinoma. Speaking as a Mohs surgeon, he nonetheless believes the class ...

EPP arises from reduced ferrochelatase activity and excess protoporphyrin made largely in the bone marrow. Accurate diagnosis ...

Without a formal staging system, advanced basal cell carcinoma is defined by the interplay of tumor size, anatomic site, depth, histology, and host factors that may not be apparent on initial biopsy.

Nemolizumab (Nemluvio) maintained improvements in skin lesions, itch, sleep disturbance, and quality of life through 3 years in adults and adolescents with moderate to severe atop ...

New data presented at the 2026 European Academy of Dermatology and Venereology (EADV) Congress highlight the effects of ...

Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.

The panel reviews years of efficacy and safety data behind today's approved HS biologics. "Long-Term Efficacy and Safety Data for HS Biologics" takes up the clinical trial evidence behind adalimumab, ...

Baricitinib (Olumiant) is FDA-approved for pediatric patients 12 years of age and older with severe alopecia areata, in ...

September marks Alopecia Areata Awareness Month, providing an opportunity to recognize the experiences of patients living with alopecia areata (AA) while reflecting on continued advances in the ...

Explore what drives male pattern hair loss, its emotional toll, and why new topical antiandrogen clascoterone may boost density while limiting systemic effects. To conclude this Dermatology Times ...